First Time Loading...
F

Fujian Aonong Biological Technology Group Incorporation Ltd
SSE:603363

Watchlist Manager
Fujian Aonong Biological Technology Group Incorporation Ltd
SSE:603363
Watchlist
Price: 4.24 CNY 3.67% Market Closed
Updated: May 19, 2024

Net Margin
Fujian Aonong Biological Technology Group Incorporation Ltd

-22.1%
Current
-8%
Average
3.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-22.1%
=
Net Income
-3.8B
/
Revenue
17B

Net Margin Across Competitors

Country Company Market Cap Net
Margin
CN
Fujian Aonong Biological Technology Group Incorporation Ltd
SSE:603363
3.7B CNY
-22%
US
Archer-Daniels-Midland Co
NYSE:ADM
30.9B USD
3%
CY
Ros Agro PLC
LSE:AGRO
24B USD
17%
US
Bunge Ltd
NYSE:BG
15B USD
4%
SG
Wilmar International Ltd
SGX:F34
19.7B SGD
2%
CN
Tongwei Co Ltd
SSE:600438
98.6B CNY
3%
US
Ingredion Inc
NYSE:INGR
7.8B USD
8%
US
Darling Ingredients Inc
NYSE:DAR
6.9B USD
8%
MY
Sime Darby Plantation Bhd
KLSE:SIMEPLT
30.9B MYR
10%
CN
New Hope Liuhe Co Ltd
SZSE:000876
45.1B CNY
0%
ID
Charoen Pokphand Indonesia Tbk PT
IDX:CPIN
86.9T IDR
4%
F
Fujian Aonong Biological Technology Group Incorporation Ltd
SSE:603363
Country CN
Market Cap 3.7B CNY
Net Margin
-22%
Archer-Daniels-Midland Co
NYSE:ADM
Country US
Market Cap 30.9B USD
Net Margin
3%
Ros Agro PLC
LSE:AGRO
Country CY
Market Cap 24B USD
Net Margin
17%
Bunge Ltd
NYSE:BG
Country US
Market Cap 15B USD
Net Margin
4%
Wilmar International Ltd
SGX:F34
Country SG
Market Cap 19.7B SGD
Net Margin
2%
Tongwei Co Ltd
SSE:600438
Country CN
Market Cap 98.6B CNY
Net Margin
3%
Ingredion Inc
NYSE:INGR
Country US
Market Cap 7.8B USD
Net Margin
8%
Darling Ingredients Inc
NYSE:DAR
Country US
Market Cap 6.9B USD
Net Margin
8%
S
Sime Darby Plantation Bhd
KLSE:SIMEPLT
Country MY
Market Cap 30.9B MYR
Net Margin
10%
New Hope Liuhe Co Ltd
SZSE:000876
Country CN
Market Cap 45.1B CNY
Net Margin
0%
Charoen Pokphand Indonesia Tbk PT
IDX:CPIN
Country ID
Market Cap 86.9T IDR
Net Margin
4%

Profitability Report

View the profitability report to see the full profitability analysis for Fujian Aonong Biological Technology Group Incorporation Ltd.

Full Profitability Report

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-22.1%
=
Net Income
-3.8B
/
Revenue
17B
What is the Net Margin of Fujian Aonong Biological Technology Group Incorporation Ltd?

Based on Fujian Aonong Biological Technology Group Incorporation Ltd's most recent financial statements, the company has Net Margin of -22.1%.

ALPHA SPREAD
Join more than 138,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.